Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Kineta Acquires Novel Drug Candidates From Airmid For Potential Treatment Of Multiple Sclerosis, Type 1 Diabetes And Other Autoimmune Diseases
Kineta, Inc. of Seattle and Airmid Incorporated of Redwood City, CA jointly announce an agreement in which a Kineta subsidiary has acquired exclusive commercial rights to a portfolio of novel therapeutic compounds from Airmid. The array of compounds holds extraordinary potential for the treatment of multiple sclerosis, type 1 diabetes mellitus and numerous other autoimmune diseases.
generic viagra online
Study Finds New Approach To Treating Heart Attacks Reduces Risk Of Life-Threatening Complications
Transferring heart attack patients to specialized hospitals to undergo angioplasty within six hours after receiving clot-busting drugs reduces the risk of life-threatening complications, according to a Canadian-led study published today. The findings, published in the New England Journal of Medicine, suggest that routine early transfer of patients after clot-busting drugs are administered results in significantly better outcomes than the current practice of transferring patients only when the clot-busting drugs fail.
News of the day
American Diabetes Association Related To Studies Published In Diabetelogia Suggesting Possible Link Between Insulin Glargine And Cancer
Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD), published a series of research papers today examining a possible link between insulin glargine (brand name, Lantus) and cancer. Findings from these research papers are conflicting and inconclusive, and the American Diabetes Association cautions against over-reaction until more information is available.
Mental Health

Rotherham Nurse Raises Alarm Over Infant Medicine Feeder

A concerned Rotherham nurse has forced manufacturers of an infant medicine feeder to withdraw its product following a safety scare. Nurse Karen Ray, a clinical procurement specialist at Rotherham Hospital, took her concerns to the Medicines and Healthcare products Regulatory Agency (MHRA) after a six-month-old baby was admitted to Rotherham Hospital following a liquid paracetamol overdose. Karen Ray told the MHRA how she feared the First Steps feeder, manufactured by RSW International Ltd, was being distributed nationwide and sold for ÷£1 in discount retail outlets, and on eBay. RSW International have now recalled all remaining stock. Karen explained: "I was worried when I saw the medicine feeder about how confusing the measurements were. The measurements were in mls and teaspoons and it was really unclear which was which. "I immediately took my concerns to the MHRA and they contacted the manufacturers. Thankfully it has now been removed from sale." MHRA Director of Device Technology and Safety, Clive Bray, said he "strongly advised" people to stop using these medicine feeders which are marketed for the administration of liquid medicines to babies and young children. "There is no evidence that the safety, quality or performance of this product has been assessed to the current standard," he said. "The product could pose a potential risk to babies or young children as the measuring scale is confusing and could be inaccurate. "This may have caused the reported overdose and we are strongly advising parents to stop using, and dispose of this product." The Rotherham NHS Foundation Trust


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009